Navigation Links
Skin Cancer More Fatal In Dark-Skinned People

A research conducted by University of Cincinnati on skin cancers has revealed that people with darker skin are also at risk for skin cancer, and when they do get //it they are associated with higher mortality rates than fair-skinned people as the diagnosis is usually done at an advanced stage.

In a report presented to the American Academy of Dermatology by Dr. Hugh Gloster, Dermatologist at University of Cincinnati, he has concluded that while fair-skinned people are at more risk to develop skin cancers, darker-skinned people are also prone it and when they do get it, it is more fatal than in fair-skinned individuals.

Dr. Gloster attributes the higher mortality rates in darker-skinned people to the cancers being diagnosed at a later stage. The belief that darker-skinned people are more immune to skin cancers because of more melanin pigmentation that protects them from the harmful ultraviolet rays of the sun makes them ignore skin changes indicative of cancers at an early stage leading to higher death rates in dark-skinned individuals.

Also, Dr. Gloster has pointed out that two of three most common types of skin cancers are not sun related as they occur primarily in sites not exposed to sun like the sole of the foot and this explains why darker-skinned people are also prone to skin cancers.

Since skin cancers in darker-skinned people occur in uncommon sites like palms, soles, fingers, toes, under the nails and mucosal surfaces like in the mouth and genitalia, regular full skin examination and self-examination can help prevent cancers. Any abnormal skin changes should be checked immediately as earlier diagnosis makes the disease less fatal. Dr. Gloster also advises the use of sunscreen in all races to help prevent skin cancers.


'"/>




Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... April 29, 2016 , ... ... team BioCellection won the $30,000 Perlman Grand Prize of the 2016 Wharton Business ... Award, the Michelson People’s Choice Award, and the Committee Award for Most ‘Wow ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... Canadian Celiac Association (CCA), is pleased to announce the launch of the ... nutritional articles, recipes, and more. The purpose of the GFCP Scoop ...
(Date:4/29/2016)... ... April 29, 2016 , ... New York City based oral and maxillofacial surgeon Dr. ... very effective way to treat obstructive sleep apnea. Dr. Jamali is proud to offer this ... procedure that involves one or both jaw bones. This surgery is performed to correct the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market ... funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... and accelerate its technology and product roadmap. , “Jvion is experiencing ...
(Date:4/29/2016)... ... 2016 , ... CURE Media Group , the nation’s ... today announced that Lynne Malestic, RN, of Eisenhower Lucy Curci Cancer Center in ... Oncology Nursing , which honors nurses who have dedicated their careers to helping ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug delivery ... upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... New York . Nadav Kidron , ... conference. Presentation Details:   PIONEERS ...
(Date:4/28/2016)... , April 28, 2016 ... Review, H1 2016" is a report that provides ... helps strengthen R&D pipelines by identifying new targets ... Company Profiles discussed in this H1 ... Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., ...
(Date:4/27/2016)... 27, 2016   ... in Recurring Consumable Sales  Clinical sales grow ... Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the ... for the first quarter ended March 31, 2016 and ... of its commercial strategy. First Quarter 2016 ...
Breaking Medicine Technology: